No Data
No Data
Rhythm Pharmaceuticals Appoints Alastair Garfield as Chief Scientific Officer
Rhythm Pharmaceuticals (RYTM) said Monday it appointed Alastair Garfield as chief scientific officer, effective July 1.Garfield most recently served as senior vice president and head of translational
Express News | Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.d., as Chief Scientific Officer
Rhythm Pharmaceuticals Says EMA Committee Backs Expanded Authorization for Obesity Drug
Rhythm Pharmaceuticals (RYTM) said Friday it had received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, recommending an expanded marketing aut
Rhythm Says European Medicines Agency's CHMP Adopted Positive Opinion Recommending Marketing Authorization For IMCIVREE; European Commission Decision Anticipated In H2 Of 2024
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization for IMCIVREE (setmelanotide) include
Express News | Rhythm Pharmaceuticals Inc - European Commission Decision Anticipated in Second Half of 2024
Express News | Rhythm Pharmaceuticals Receives Positive Chmp Opinion for ▼Imcivree® (Setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients Between 2 and 6 Years Old With Bardet Biedl Syndrome or Pomc, Pcsk1, or Lepr Deficiency